Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
CanSense
CanSense is a diagnostic company focused on early detection of bowel (colorectal) cancer through a non-invasive, cost-effective, and scalable blood test. Their technology combines laser spectroscopy…
CanSense
CanSense is a diagnostic company focused on early detection of bowel (colorectal) cancer through a non-invasive, cost-effective, and scalable blood test. Their technology combines laser spectroscopy…
TL;DR
What they do: Develop a non-invasive blood test for early detection of bowel (colorectal) cancer using laser spectroscopy and AI analytics
HQ: Swansea, United Kingdom
Stage / funding: Seed-stage; reported seed investors include Development Bank of Wales, Mercia Fund Managers, Nonacus
Founded: 2018
Headcount: Around 11–50 (reported 17)
Company Overview
Problem Domain
Early detection of colorectal (bowel) cancer; reducing invasive diagnostic procedures and supporting clinical trials.
Founded
2018
Industry
Biotechnology
Funding Track Record
3142306
Reported seed funding round; Dealroom also reports a £1.5M seed round in 2023 (currencies reported in sources differ)
Investor Signal
“Development Bank of Wales; Mercia Fund Managers; Nonacus”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,600+
New This Week